<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01919151</url>
  </required_header>
  <id_info>
    <org_study_id>93-08172d6.2008.540</org_study_id>
    <nct_id>NCT01919151</nct_id>
  </id_info>
  <brief_title>Micrometastasis in Gastrointestinal Cancer</brief_title>
  <official_title>The Process of Metastasis in Colorectal Cancer Tumour Biology and Prognostic Factors in Pancreatic Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prognostic and predictive value of assessing the patients micrometastasis status in blood and
      bone marrow when diagnosed GI cancer. 2 different patient subgroups are currently studied,
      patients with cancer of the pancreas and patients with liver metastasis secondary to
      colorectal cancer.

      Our hypothesis is that patients with detective circulating tumor cells in the blood or
      disseminated tumour cells in their bone marrow at diagnosis have a more advanced disease than
      negative patients. This information may be of therapeutic interest.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oncological and overall outcome of the included patients are consecutively registrated at the
      out-patient clinic. At end of follow-up these survival data are analysed according to the
      presence of tumor cells in blood and bone marrow, and the prognostic impact of their presence
      are assessed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2008</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>5 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Pancreatic Adenocarcinoma</condition>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Gastrointestinal cancer patients</arm_group_label>
    <description>Patients with radiological suspected cancer in the pancreas Patients with radiological suspected colorectal liver metastasis</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and bone marrow cells fixated to slides or to cartridge. Some fresh frozen tumor
      samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Gastrointestinal cancer patients:

          1. patients with suspected adenocarcinoma in the pancreas

          2. patients with liver metastases secondary to colorectal cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Histological proven adenocarcinoma of the pancreas

          2. Histological/radiological verified colorectal liver metastases

          3. Consent capable patient

          4. Signed written, informed consent

        Exclusion Criteria:

        1. Patient'history of other malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bjørn Atle Bjørnbeth, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Oslo University Hospital, Dep of Gastrointestinal surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gro Wiedswang, MD,PhD</last_name>
    <phone>+4722119550</phone>
    <email>uxgrie@ous-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Evi Faleide, MD,PhD</last_name>
    <phone>+4722118080</phone>
    <email>UXEVAL@us-hf.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gro Wiedswang, MD,PhD</last_name>
      <phone>+47 22119550</phone>
      <email>uxgrie@ous-hf.no</email>
    </contact>
    <investigator>
      <last_name>Gro Wiedswang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2013</study_first_submitted>
  <study_first_submitted_qc>August 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2013</study_first_posted>
  <last_update_submitted>August 8, 2013</last_update_submitted>
  <last_update_submitted_qc>August 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Adenocarcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

